159 related articles for article (PubMed ID: 37635085)
1. Acalabrutinib and steroid for autoimmune thrombocytopenia due to relapsed chronic lymphocytic leukemia with severe bone marrow infiltration.
Oyama T; Yasunaga M; Jona M; Nishikawa M; Yatomi Y; Honda A; Maki H; Morita K; Masamoto Y; Kurokawa M
J Clin Exp Hematop; 2023 Sep; 63(3):187-192. PubMed ID: 37635085
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
Wells T; Kovacs MJ
Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
[TBL] [Abstract][Full Text] [Related]
3. CD5-negative chronic lymphocytic leukemia with indolent clinical course and autoimmune thrombocytopenia, successfully treated with rituximab.
Okamoto M; Nakano S; Namura K; Yamada N; Uchida R; Fuchida S; Okano A; Ochiai N; Shimazaki C
Am J Hematol; 2004 Dec; 77(4):413-5. PubMed ID: 15551407
[TBL] [Abstract][Full Text] [Related]
4. [B-cell chronic lymphocytic leukemia complicated by autoimmune thrombocytopenic purpura].
Komatsuda A; Lee M; Nishinari T; Nishimura S; Chubachi A; Endo Y; Nakamoto Y; Miura A
Rinsho Ketsueki; 1992 Feb; 33(2):200-4. PubMed ID: 1635169
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
Cortes J; O'Brien S; Loscertales J; Kantarjian H; Giles F; Thomas D; Koller C; Keating M
Cancer; 2001 Oct; 92(8):2016-22. PubMed ID: 11596014
[TBL] [Abstract][Full Text] [Related]
6. Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.
Hegde UP; Wilson WH; White T; Cheson BD
Blood; 2002 Sep; 100(6):2260-2. PubMed ID: 12200396
[TBL] [Abstract][Full Text] [Related]
7. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
[TBL] [Abstract][Full Text] [Related]
8. Association between immune thrombocytopenic purpura and chronic lymphocytic leukemia in a patient carrier of anti-hepatitis C virus antibodies.
Numeroso F; Baroni MC; Delsignore R
Ann Ital Med Int; 2005; 20(3):197-202. PubMed ID: 16250187
[TBL] [Abstract][Full Text] [Related]
9. [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia].
Telek B; Batár P; Uvardy M
Orv Hetil; 2005 Aug; 146(34):1791-3. PubMed ID: 16184881
[TBL] [Abstract][Full Text] [Related]
10. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kyasa MJ; Parrish RS; Schichman SA; Zent CS
Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
[TBL] [Abstract][Full Text] [Related]
12. A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.
Tsang M; Parikh SA
Curr Hematol Malig Rep; 2017 Feb; 12(1):29-38. PubMed ID: 28197963
[TBL] [Abstract][Full Text] [Related]
13. Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
Visco C; Ruggeri M; Laura Evangelista M; Stasi R; Zanotti R; Giaretta I; Ambrosetti A; Madeo D; Pizzolo G; Rodeghiero F
Blood; 2008 Feb; 111(3):1110-6. PubMed ID: 17986663
[TBL] [Abstract][Full Text] [Related]
14. Eltrombopag for resistant immune thrombocytopenia secondary to chronic lymphocytic leukaemia.
Jolliffe E; Romeril K
Intern Med J; 2014 Jul; 44(7):697-9. PubMed ID: 25041772
[TBL] [Abstract][Full Text] [Related]
15. Variant Richter's syndrome: a rare case of classical Hodgkin's lymphoma developing in a patient with chronic lymphocytic leukemia treated with fludarabine.
Nemets A; Ben Dor D; Barry T; Ducach A; Blumental R; Ben Alon D; Lugassy G
Leuk Lymphoma; 2003 Dec; 44(12):2151-4. PubMed ID: 14959863
[TBL] [Abstract][Full Text] [Related]
16. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
Kaufman M; Limaye SA; Driscoll N; Johnson C; Caramanica A; Lebowicz Y; Patel D; Kohn N; Rai K
Leuk Lymphoma; 2009 Jun; 50(6):892-9. PubMed ID: 19391041
[TBL] [Abstract][Full Text] [Related]
17. Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database.
Ammad Ud Din M; Mahmud A; Mostafa M; Shahzad M; Liaqat H; Pinilla-Ibarz J; Jaglal M
Ann Hematol; 2023 Apr; 102(4):889-895. PubMed ID: 36781419
[TBL] [Abstract][Full Text] [Related]
18. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.
Fujimaki K; Takasaki H; Koharazawa H; Takabayashi M; Yamaji S; Baba Y; Kanamori H; Ishigatsubo Y
Leuk Lymphoma; 2005 Jul; 46(7):1101-2. PubMed ID: 16019566
[TBL] [Abstract][Full Text] [Related]
20. Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone.
Bowen DA; Call TG; Shanafelt TD; Kay NE; Schwager SM; Reinalda MS; Rabe KG; Slager SL; Zent CS
Leuk Lymphoma; 2010 Apr; 51(4):620-7. PubMed ID: 20302386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
